好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Estimating an Individual’s Risk of Parkinson’s Disease based on Comprehensive Family History
Movement Disorders
P3 - Poster Session 3 (5:30 PM-6:30 PM)
10-040

To identify relative risk of Parkinson’s disease-related death based on comprehensive family history.

There is an inherited component to risk for Parkinson’s disease (PD). Most studies estimating the risk to individuals in a family have focused on close relatives.

A unique Utah population resource, including a genealogy of Utah pioneers from the mid-1800s linked to Utah death certificates, was used to estimate the risk for PD-related death based on family history of PD death. The analysis included first- to third-degree relatives.

We first estimated the risk of PD-related death based on the number of affected first-degree relatives, rather than the typical estimate of risk based on presence or absence of any first-degree family history. The data showed increasing relative risk (RR) with one, two, and three first-degree relatives with PD-related death. Then we estimated the RR for PD-related death based on the number of affected second-degree relatives in two scenarios. With PD-related deaths in second-, but not in first- and third-degree relatives, RR was not significantly increased. In contrast, in the presence of exactly one PD-related death in a first-degree relative, the RR increased from 1.34 to 2.10 going from one to two PD-related deaths in second-degree relatives. Due to the small number of cases, the analysis could not be performed with three affected second-degree relatives. We then estimated the RR for PD-related death based on the number of affected third-degree relatives in the absence of any affected first- and second-degree relatives. The RR for PD-related death was not increased.

These data provide proof-of-concept of the feasibility of developing individual estimates of PD-related death, based on comprehensive knowledge of family history of PD-related death. Further refinements of this approach are planned using population-based medical record data.
Authors/Disclosures
Paolo M. Moretti, MD (University of Utah)
PRESENTER
The institution of Dr. Moretti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Inc. The institution of an immediate family member of Dr. Moretti has received research support from NIH. The institution of an immediate family member of Dr. Moretti has received research support from VHA. The institution of an immediate family member of Dr. Moretti has received research support from DOD.
Stefan M. Pulst, MD, FAAN (University of Utah) Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file